Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density

Richard Eastell, Dennis M Black, Steven Boonen, Silvano Adami, Dieter Felsenberg, Kurt Lippuner, Steven R. Cummings, Pierre D. Delmas, Lisa Palermo, Peter Mesenbrink, Jane A. Cauley, Horizon Pivotal Fracture Trial, W. D. Fraser

Research output: Contribution to journalArticle

98 Citations (Scopus)

Abstract

ZOL appeared more effective in preventing vertebral fracture in younger women, overweight/obese women, and women with normal renal function. ZOL had similar effects irrespective of fracture risk factors or femoral neck BMD.
Original languageEnglish
Pages (from-to)3215-3225
Number of pages11
JournalThe Journal of Clinical Endocrinology and Metabolism
Volume94
Issue number9
DOIs
Publication statusPublished - Sep 2009

Cite this